"Nimustine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antineoplastic agent especially effective against malignant brain tumors. The resistance which brain tumor cells acquire to the initial effectiveness of this drug can be partially overcome by the simultaneous use of membrane-modifying agents such as reserpine, calcium antagonists such as nicardipine or verapamil, or the calmodulin inhibitor, trifluoperazine. The drug has also been used in combination with other antineoplastic agents or with radiotherapy for the treatment of various neoplasms.
Descriptor ID |
D015376
|
MeSH Number(s) |
D02.654.692.550 D02.948.594.550
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nimustine".
Below are MeSH descriptors whose meaning is more specific than "Nimustine".
This graph shows the total number of publications written about "Nimustine" by people in this website by year, and whether "Nimustine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nimustine" by people in Profiles.
-
Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells. Cancer Res. 1997 Dec 01; 57(23):5292-9.
-
Posttranscriptional regulation of MRP/GS-X pump and gamma-glutamylcysteine synthetase expression by 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea and by cycloheximide in human glioma cells. Biochem Biophys Res Commun. 1997 Oct 09; 239(1):51-6.